SMTL ID : 6xdd.3 (2 other biounits)

Crystal structure of IRE1 in complex with G-3053

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x N97: 4-[(trans-4-aminocyclohexyl)amino]-N-(6-chloro-3-{[(2,5-difluorophenyl)sulfonyl]amino}-2-fluorophenyl)thieno[3,2-d]pyrimidine-7-carboxamide(Non-covalent)

N97.1: 22 residues within 4Å: Chain A: V.40, A.51, V.52, K.53, E.66, V.67, L.70, I.80, Y.82, I.94, I.96, E.97, L.98, C.99, A.100, A.101, E.105, L.149, S.164, D.165, F.166, G.167 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.40, A:K.53, A:L.70, A:I.80, A:Y.82, A:I.94, A:I.96 Hydrogen bonds: A:K.53, A:C.99, A:C.99, A:E.105, A:D.165, A:F.166

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Beveridge, R.E. et al., Identification of BRaf-Sparing Amino-Thienopyrimidines with Potent IRE1 alpha Inhibitory Activity. Acs Med.Chem.Lett. (2020)

Release Date

2021-04-21

Peptides

Serine/threonine-protein kinase/endoribonuclease IRE1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Serine/threonine-protein kinase/endoribonuclease IRE1

Related Entries With Identical Sequence